Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae.
Tsala, Marilena; Vourli, Sophia; Daikos, George L; Tsakris, Athanassios; Zerva, Loukia; Mouton, Johan W; Meletiadis, Joseph.
J Antimicrob Chemother
; 72(1): 172-180, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27650184
Re-defining tigecycline therapy.
Determination of tigecycline in human plasma by LC-MS/MS and its application to population pharmacokinetics study in Chinese patients with hospital-acquired pneumonia.
Minocycline for acne vulgaris: efficacy and safety.
Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
Determination of tigecycline in turkey plasma by LC-MS/MS: validation and application in a pharmacokinetic study.
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease.
Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.
In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.
Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin.